Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
PACS GroupPACS -3.03%19 Debt-to-EBITDA is 6.09 as of Mar. 2026, which is 43% below its 10-year median of 10.73. GuruFocus rates PACS with a GF Score™ of 19/100. The stock has 6 warning signs investors should review. Among 477 Healthcare Providers & Services companies, PACS Group ranks worse than 85.53% on this metric.
Debt-to-EBITDA measures a company's ability to pay off its debt.
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
The historical rank and industry rank for PACS Group's Debt-to-EBITDA or its related term are showing as below:
PACS'
s Debt-to-EBITDA Range Over the Past 10 Years
Min: 7.55 Med: 10.73 Max: 18.75
Current: 7.57
During the past 5 years, the highest Debt-to-EBITDA Ratio of PACS Group was 18.75. The lowest was 7.55. And the median was 10.73.
PACS's Debt-to-EBITDA is ranked worse than 85.53% of 477
companies
in the Healthcare Providers & Services industry
Industry Median: 2.22
vs PACS: 7.57
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.
According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
PACS Group Debt-to-EBITDA Related Terms
PACS Group Debt-to-EBITDA Historical Data
* Premium members only.
The historical data trend for PACS Group's Debt-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, PACS Group's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PACS Group Debt-to-EBITDA vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, PACS Group's Debt-to-EBITDA distribution charts can be found below:
* The bar in red indicates where PACS Group's Debt-to-EBITDA falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data,
the EBITDA data used here is four times the quarterly (Mar. 2026) EBITDA data.
PACS Group (PACS) has a Debt-to-EBITDA of 6.09 as of Mar. 2026. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on PACS Group. This is 43% below median its historical median of 10.73. Over the past decade, PACS Group's Debt-to-EBITDA has ranged from 7.55 to 18.75. According to the industry distribution chart, PACS Group ranks #408 out of 477 companies in the Healthcare Providers & Services industry, placing it in the top 85.5%.
Is PACS Group's Debt-to-EBITDA too high?
PACS Group's current Debt-to-EBITDA of 6.09 is 43% below median its 10-year median of 10.73. Over the past 10 years, this metric has ranged from a low of 7.55 to a high of 18.75. The Healthcare Providers & Services industry median Debt-to-EBITDA is 2.22. PACS Group's value of 6.09 is 174.3% above this industry median. Based on the distribution chart, PACS Group ranks #408 out of 477 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, PACS Group has a GF Score™ of 19/100, reflecting its overall financial health beyond just this single metric.
How does PACS Group's Debt-to-EBITDA compare to CHE and UHS?
According to the Healthcare Providers & Services industry distribution chart, PACS Group ranks #408 out of 477 companies for Debt-to-EBITDA. This places PACS Group in the lower half of its industry. The industry median Debt-to-EBITDA is 2.22. PACS Group's value of 6.09 is 174.3% above this benchmark. Historically, PACS Group's own Debt-to-EBITDA has ranged from 7.55 to 18.75 over the past decade. While the company's 10-year median is 10.73 vs. the industry median of 2.22, PACS Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-EBITDA for a Healthcare Providers & Services company?
The median Debt-to-EBITDA among Healthcare Providers & Services companies is 2.22, based on 477 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PACS Group's current Debt-to-EBITDA of 6.09 is 174.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-EBITDA mean?
A high Debt-to-EBITDA can signal that a stock is expensive relative to its fundamentals. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on PACS Group. For the Healthcare Providers & Services industry, the median Debt-to-EBITDA is 2.22 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PACS Group's current Debt-to-EBITDA is 6.09, which is 43% below median its own 10-year median of 10.73. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PACS Group stock overvalued right now?
PACS Group (PACS) has a current Debt-to-EBITDA of 6.09. The current Debt-to-EBITDA is 6.09, which is 43% below median its 10-year median of 10.73 and 174.3% above the Healthcare Providers & Services industry median of 2.22. PACS Group's overall GF Score™ is 19/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-EBITDA calculated?
Debt-to-EBITDA is calculated from a company's financial statements. For PACS Group (PACS), the current Debt-to-EBITDA is 6.09 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
PACS Group Inc is a post-acute healthcare company mainly focused on delivering skilled nursing care through a portfolio of independently operated facilities. The post-acute care ecosystem serves individuals who need additional help recuperating from acute conditions, illnesses, or serious medical procedures after getting discharged from the hospital. It also provides senior care, assisted living, and independent living options in some of the communities. The company has one reportable segment.
19GF Score
Get the complete analysis for PACS
Debt-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PACS has been successfully added to your 
